Who is md anderson

Overview

MD Anderson Cancer Center is one of the world’s most respected institutions dedicated exclusively to cancer care, research, and education. Based in Houston, Texas, it operates as part of The University of Texas System and has consistently ranked as the top cancer hospital in the United States.

Since its founding, MD Anderson has pioneered breakthroughs in oncology, including targeted therapies, immunotherapies, and precision medicine. Its global reputation attracts patients, researchers, and clinicians from around the world seeking advanced treatment and clinical trials.

• Founded in 1941, MD Anderson opened its doors after a $500,000 donation from Monroe Dunaway Anderson, a Memphis businessman whose estate funded the initial endowment.
• The center is located in the Texas Medical Center, the largest medical complex in the world, housing over 50 healthcare institutions and 100,000 employees.
• In 2023, U.S. News & World Report ranked MD Anderson as the #1 cancer hospital in the nation for the eighth consecutive year.
• MD Anderson treats more than 155,000 unique patients annually, including individuals from all 50 U.S. states and over 100 countries.
• The institution employs over 21,000 staff members, including 1,800+ physicians and scientists, making it the largest cancer center by workforce in the world.

How It Works

MD Anderson integrates clinical care, research, and education through a multidisciplinary model that emphasizes collaboration across specialties. This approach enables rapid translation of scientific discoveries into patient treatments.

• Cancer Moon Shots Program: Launched in 2012, this initiative targets 13 major cancer types with the goal of reducing cancer deaths by 50% over a decade using genomics and immunotherapy.
• Personalized Cancer Therapy: Over 70% of patients at MD Anderson undergo genomic tumor profiling to guide treatment decisions tailored to their genetic makeup.
• Clinical Trials: The center offers more than 1,200 active clinical trials, enrolling over 12,000 patients each year in studies testing novel drugs and therapies.
• Global Outreach: MD Anderson partners with 80+ institutions in 40 countries to train oncologists and implement cancer control programs in underserved regions.
• Prevention & Screening: The institution’s 7,000+ annual screenings for high-risk individuals have led to early detection in over 25% of cases, improving survival rates.
• Education & Training: MD Anderson trains over 1,500 fellows and residents annually, producing leaders in oncology through programs accredited by the Accreditation Council for Graduate Medical Education.

Comparison at a Glance

Below is a comparison of MD Anderson with four other leading U.S. cancer centers based on U.S. News rankings, patient volume, research funding, and specialty excellence.

This table highlights MD Anderson’s leadership in patient volume and research funding. Its consistent #1 ranking reflects its comprehensive capabilities, from early detection to complex surgical interventions and cutting-edge drug development. The center’s scale and integration of services set it apart from peers.

Why It Matters

MD Anderson’s impact extends beyond individual patient care to shaping the future of oncology worldwide. Its research and treatment models influence standards of care across the globe.

• Survival rate improvements: MD Anderson has contributed to a 30% increase in five-year survival rates for certain cancers, including leukemia and melanoma, since 2000.
• Immunotherapy breakthroughs: Researchers at MD Anderson developed ipilimumab and pembrolizumab, now FDA-approved drugs that revolutionized melanoma treatment.
• Global cancer control: Through partnerships, MD Anderson helped reduce cervical cancer mortality by 40% in select Latin American countries via vaccination and screening programs.
• Economic impact: The center generates over $8 billion in annual economic impact for the Houston region and supports more than 40,000 jobs.
• Policy influence: MD Anderson experts regularly advise the National Cancer Institute and WHO on cancer research priorities and public health strategies.
• Education leadership: Its Anderson Fellows Program has trained over 5,000 international oncologists since 2000, expanding access to expert care globally.

By combining innovation, scale, and global outreach, MD Anderson continues to lead the fight against cancer, setting benchmarks for quality, research output, and patient outcomes in oncology.